Denmark· DK-28107479225
Atrovent
A ipratropium bromide product containing ipratropiumbromidmonohydrat, registered in Denmark by Epione Medicine ApS. The same ATC class is registered in 13 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Ipratropium bromide is registered in 13 of 19 countries.
Countries holding a registration under ATC R03BB01 (ipratropium bromide), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 8 of them publish a price we can compare per daily dose
Ipratropium bromide · ATC R03BB01
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Statesprice
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- IPRATROPIUMBROMIDMONOHYDRAT
- Manufacturer
- Epione Medicine ApS
- Country
- Denmark (DK)
- ATC code
- R03BB01
- ATC class
- Ipratropium bromide
- Defined daily dose
- 0.12 mg, Inhal
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28107479225
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
114 interactions on record for ipratropium bromide.
Graded by severity as the source publishes them — 114 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ipratropium bromide · interactions on record
114 records
- 114 moderate
Most severe, free to view
- DicycloverineA03AA07moderate
- PropanthelineA03AB05moderate
- MepenzolateA03AB12moderate
- TrospiumA03AB20moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under R03BB01
Ipratropium bromide, as other registers publish it.
- CanadaAA-IPRAVENTAA PHARMA INC
- PolandAtrodilZakłady Farmaceutyczne POLPHARMA S.A.
- FinlandAtroventBoehringer Ingelheim International GmbH
- FinlandAtroventBoehringer Ingelheim International GmbH
- FinlandAtroventBoehringer Ingelheim International GmbH
- FinlandAtroventBoehringer Ingelheim International GmbH
- FinlandAtroventBoehringer Ingelheim International GmbH
- FinlandAtroventParanova Oy
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d0847cf4-e839-4b4a-bc7c-bf7988ba37c9 GET /v1/drugs/d0847cf4-e839-4b4a-bc7c-bf7988ba37c9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "inhalationsspray, opløsning",
"source": "dkma",
"strength": "20 mikrogram/dosis",
"auth_role": "DKMA",
"dk_drugid": "28107479225",
"substance": "IPRATROPIUMBROMIDMONOHYDRAT",
"auth_procedure": "Par-Imp",
"in_medicinpriser": true,
"registration_date_serial": "45985"
}See everything about ipratropium bromide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.